January 16, 2015
Sumitomo Dainippon Pharma and its US subsidiary Sunovion Pharmaceuticals have filed lawsuits against three generic drug firms for the patent infringement of the antipsychotic agent Latuda (lurasidone), Sumitomo Dainippon said on January 15. The two companies jointly filed lawsuits with...read more